Pregnancy.
Conditions
Interventions
Intervention 1: Intervention group: taking oral hyoscine 10 mg twice daily for one week and then once a day in the second week since entering the study (39-40 weeks). Intervention 2: Control group: Ex
Sponsors
Shahid Beheshti University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Age older than 18 years Primiparous Gestational age of 39 weeks and 0 days to 40 weeks and 0 days Spontaneous pregnancy Singleton pregnancy Cephalic presentation Bishop score equal to or less than 5
Exclusion criteria
Exclusion criteria: The existence of a placenta previa or placenta detachment (decollement) Fetal distress The presence of IUGR or macrosomal infant (embryo weighing more than 4000 gr) The presence of underlying illness, such as diabetes or pre-pregnancy or pre-pregnancy hypertension History of cervix trauma Hyoscine susceptibility History of cervical or uterine surgery Using narcotic drugs or analgesics The presence of glaucoma The presence of cardiovascular disease or tachycardia more than 100 beats per minute
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Cervix status. Timepoint: At the time of entering the design, 24 hours later, and then every 72 hours until delivery and at the time of delivery. Method of measurement: The Bishop Score gives points to 5 measurements of the pelvic examination dilation, effacement of the cervix, station of the fetus, consistency of the cervix, and position of the cervix and its rage is 0 to 13. | — |
Secondary
| Measure | Time frame |
|---|---|
| Gestational age at delivery time. Timepoint: At delivery time. Method of measurement: Ask the patient.;Delivery type. Timepoint: At delivery. Method of measurement: Normal vaginal delivery (NVD), Cesarean section (C/S). | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactZahra Naeiji
Shahid Beheshti University of Medical Sciences
Outcome results
None listed